# Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

> **NIH NIH U01** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2020 · $2,339,500

## Abstract

Project Summary
A key to the success of the Consortium for the Study of Chronic Pancreatitis, Diabetes and
Pancreatic Cancer (Consortium) lies in effective communication and collaboration among
scientists in multiple disciplines; strong study design for discovery and validation of biomarkers
characterizing complex interactions between chronic pancreatitis (CP), diabetes mellitus (DM),
and pancreatic cancer (PDAC), and evaluation of novel intervention strategies; robust and high-
quality data and specimen collection; and rigorous study execution of Consortium collaborative
protocols. In the last four and a half years, the Coordination and Data Management Center
(CDMC) has provided strong scientific, administrative, regulatory, managerial, logistic, and
analytic supports to the Consortium, enabling the successful launch of three longitudinal cohort
studies (i.e., PROCEED, INSPPIRE 2, and NOD) that aim to understand the relationship
between CP, DM, and PDAC; and two other studies (i.e., DETECT and DEPICT (in planning))
that aim to better define and characterize Type 3c diabetes (T3cDM). In the next five years, the
overall CDMC aim is to further refine and optimize the center's time-tested infrastructure,
operations procedures, and organizational structure to provide strong and continual
supports to the Consortium's existing and new studies, and address any emerging
challenges associated with the progress of the studies from the accrual phase to the follow-
up and dissemination phases. Specifically, we aim to (i) provide operation and coordination
of the Consortium; (ii) provide supports to continue the accrual and follow up of patients in
Consortium-approved studies; (iii) provide the infrastructure for biomarker development,
prevention studies, and therapeutic trials; and (iv) design and support new studies and disease
prevention.

## Key facts

- **NIH application ID:** 10073624
- **Project number:** 2U01DK108328-06
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Liang Li
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,339,500
- **Award type:** 2
- **Project period:** 2015-09-28 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10073624

## Citation

> US National Institutes of Health, RePORTER application 10073624, Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC) (2U01DK108328-06). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10073624. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*